Carolyn Cutre
Optometrist · Cicero, NYNPI 1831138510
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $28,500 of the $32,729 with a category attached, or 87.1%. Clerio Vision, Inc accounts for 87.1% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2022 at $28,752 and has fallen 96.9% since, to $889 in 2025. Among optometrist clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 71 payments — averaging $460.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Clerio Vision, Inc$29K
- Alcon$1K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$654
- Coopervision Inc.$625
- Bausch & Lomb Americas Inc.$460
- Biotissue Holdings Inc.$244
- plus $1K from 14 others
What the payments were for
- Consulting fees$28,50087%
- Food & beverage$4,18213%
- Entertainment$480%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Clerio Vision, Inc | 1 | $28,500 |
| Alcon | 17 | $1,180 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 11 | $654 |
| Coopervision Inc. | 15 | $625 |
| Bausch & Lomb Americas Inc. | 6 | $460 |
| Biotissue Holdings Inc. | 4 | $244 |
| Sight Sciences, Inc. | 2 | $237 |
| Optos, Inc. | 2 | $142 |
| Tarsus Pharmaceuticals, Inc. | 1 | $109 |
| Harrow Eye, LLC | 1 | $96 |
| Dompe US, Inc. | 1 | $94 |
| Tearlab Corp | 1 | $77 |
| Amgen | 1 | $70 |
| Johnson & Johnson Vision Care, Inc. | 2 | $59 |
| Optovue, Inc. | 1 | $59 |
| ABB Con-cise Optical Group LLC | 1 | $56 |
| Aerie Pharmaceuticals, Inc. | 1 | $22 |
| Carl Zeiss Meditec, Inc. | 1 | $18 |
| Topcon Healthcare, Inc. | 1 | $13 |
| AbbVie | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXTREME H20$28,500
- INFUSE$534
- Precision 1$513
- TOTAL30$243
- DAILIES TOTAL1$126
- OMNI(R) SURGICAL SYSTEM (US)$125
- ULTRA$120
- Precision7$115
- MIEBO$114
- XIIDRA$114
- TearCare SmartLid$112
- TEARCARE(TM) (2.2) SYSTEM KIT$112
- SIMBRINZA$110
- Rocklatan$110
- Rhopressa$110
- XDEMVY$109
- MiSight Contact Lens$105
- MyDay Contact Lens$101
How this compares
$32,729 in reported general payments places this provider in the 95th percentile of 2,743 optometrist providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Timolol Maleate | 27 | $929 |
| Latanoprost | 55 | $324 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Cicero
- Roy KlineLake Katrine$822K
- Susan ResnickNew York$463K
- Murray FingeretHewlett$374K
- Albert MorierSlingerlands$347K
- Denise WhittamNew York$343K
- Justin BazanBrooklyn$303K
- Jennifer TsaiNew York$275K
- Alexander KabiriQueens Village$268K
- Sophia VisanjiNew York$233K
- Jason ComptonNew York$181K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.